MEKINIST (Trametinib) 2 mg Capsules
Description of Mekinist (Trametinib)
Mekinist is indicated for Metastatic Melanoma. It should only be used for people whose Cancer has a particular mutation in a gene called “BRAF”.
Treatment related info
For treatment related information, please consult your treating Physician.
Mekinist tablets are supplied as 0.5 mg, 1 mg and 2 mg tablets for oral administration
0.5 mg Tablets – Yellow, modified oval, biconvex, film-coated tablets
1.0 mg Tablets – White, round, biconvex, film-coated tablets
2.0 mg Tablets – Pink, round, biconvex, film-coated tablets
Storage and handling
Store at 2°- 8° C, Do not Freeze. Protect from moisture and light
How do we source the Drug?
Super Specialities Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Company that Manufactures/ Markets:
M/s GlaxoSmithKline (GSK)
Mob No: +91 7738100125, +91 7738151650
E Mail: firstname.lastname@example.org